Learn More
Log In
Sign Up
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species | Midpage
Collections
Code of Federal Regulations
Title 21
Chapter I
Subchapter E
Part 516
Subpart C
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
516.111
Scope of this subpart.
516.115
Definitions.
516.117
Submission of correspondence under this subpart.
516.119
Permanent-resident U.S. agent for foreign requestors and holders.
516.121
Meetings.
516.123
Informal conferences regarding agency administrative actions.
516.125
Investigational use of minor species new animal drugs to support indexing.
516.129
Content and format of a request for determination of eligibility for indexing.
516.131
Refuse to file a request for determination of eligibility for indexing.
516.133
Denying a request for determination of eligibility for indexing.
516.135
Granting a request for determination of eligibility for indexing.
516.137
Notification of decision regarding eligibility for indexing.
516.141
Qualified expert panels.
516.143
Written report.
516.145
Content and format of a request for addition to the index.
516.147
Refuse to file a request for addition to the index.
516.149
Denying a request for addition to the index.
516.151
Granting a request for addition to the index.
516.153
Notification of decision regarding index listing.
516.155
Labeling of indexed drugs.
516.157
Publication of the index and content of an index listing.
516.161
Modifications to indexed drugs.
516.163
Change in ownership of an index file.
516.165
Records and reports.
516.167
Removal from the index.
516.171
Confidentiality of data and information in an index file.